Pulmonary Hypertension Study: The Prostacyclin Pathway

Dr. Vallerie McLaughlin talks about the role of the prostacyclin pathway in pulmonary hypertension (PH). Dr. McLaughlin is a specialist in Cardiology and Internal Medicine at the University of Michigan Frankel Cardiovascular Center and was involved in GRIPHON, a large study of pulmonary hypertension that led to the approval of Selexipag, an oral drug for PH.

Keep updated on all the latest PH news here: http://bit.ly/20LXxHN

Leave a Comment

Your email address will not be published. Required fields are marked *